Often there is a silent killer lurking beneath the skin, turning orthopedic implants into ticking time bombs of infection—resistant to antibiotics, devastating mobility, and costing billions in healthcare agony.
Enter BioPrax: a groundbreaking electrochemical weapon poised to zap bacterial biofilms off metallic joints, saving limbs and lives without the trauma of replacement surgery. Dive into the science that's electrifying orthopedic medicine.
Overview of BioPrax TechnologyBioPrax is an innovative medical device developed by Garwood Medical Devices, LLC, a Buffalo, New York-based company specializing in infection control solutions. The technology targets bacterial biofilm infections on metallic orthopedic implants, particularly prosthetic knee joints, which are a major complication in joint replacement surgeries. These infections, known as periprosthetic joint infections (PJIs), affect approximately 50,000 knee and hip replacement patients annually in the U.S. alone, contributing to an estimated $2 billion in healthcare costs due to prolonged treatments, revision surgeries, and patient suffering.
website - https://garwoodmedicaldevices.com/
BioPrax aims to disrupt biofilms—a pr...
